http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2442857-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-075 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-06 |
| filingDate | 2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9643d012973e2ca09b242418c667398 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39c877cd5f3e3d1693817ca5555b717a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9a465f3a155742b667a84d1a4524475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17ebb206e1873053e4b0ac18039f7c6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f85636615c12410a36e71eead4bbd5fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd353bc9b009350567061c9d0ce4b4a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a269773a695bc67fd4e38fcf025a788 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aca18db9f6eb466d9c540e208b783791 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1b13c52d5d2891347c9170eaf8f9d55 |
| publicationDate | 2014-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2442857-T3 |
| titleOfInvention | 1,2,4-Triazin-6-one HIV inhibitor derivatives |
| abstract | A compound of formula ** Formula ** or an N-oxide, a pharmaceutically acceptable addition salt or a stereochemically isomeric form thereof, wherein: ring A represents phenyl; ring B represents phenyl; n is 1, 2, 3 or 4; m is 1, 2, 3 or 4; R1 represents hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6 alkyloxycarbonyl; C1-6alkyl optionally substituted with R5; or C1-6 alkyloxyC1-6alkylcarbonyl substituted with C1-6alkyloxycarbonyl; each R2 independently represents hydrogen; hydroxy; halo; C1-6alkyl optionally substituted with one or more substituents each independently selected from halo, cyano, hydroxy or -C (> = O) R6; C2-6alkenyl optionally substituted with one or more substituents each independently selected from halo, cyano, hydroxy or -C (> = O) R6; C2-6alkynyl optionally substituted with one or more substituents each independently selected from halo, cyano, hydroxy or -C (> = O) R6; C3-7 cycloalkyl; C1-6 alkyloxy; C1-6 alkyloxycarbonyl; C 1-6 alkylcarbonyloxy; carboxyl; cyano; nitro; Not me; mono- or di (C1-6alkyl) amino; polyhaloC1-4alkyl; C1-4 polyhaloalkyloxy; C1-4 polyhaloalkylthio; -S (> = O) pR6; -NH-S (> = O) pR6; -C (> = O) R6; -NHC (> = O) H; -C (> = O) NHNH2; NHC (> = O) R6; C (> = NH) R6; or R7; R2a represents cyano; aminocarbonyl; Not me; halo; NHR13; NR13R14; -C (> = O) -NHR13; -C (> = O) -NR13R14; -C (> = O) -R15; -CH> = N-NH-C (> = O) -R16; C1-6 alkyl optionally substituted with one or more substituents each independently selected from halo, cyano, hydroxy, NR9R10, -C (> = O) -NR9R10, -C (> = O) -C1-6 alkyl, -C (> = O) -O-C1-6 alkyl, -C (> = O) -polyhaloalkyl C1-6, -C (> = O) -O-polyhaloalkylC1-6 or R7; C1-6 alkyloxy optionally substituted with one or more substituents each independently selected from halo, cyano, hydroxy, NR9R10, -C (> = O) -NR9R10, -C (> = O) -C1-6 alkyl, -C (> = O) -O-C1-6-alkyl, -C (> = O) -polyhaloalkyl-C1-6, -C (> = O) -O-polyhaloalkyl-C1-6 or R7; C1-6 alkyloxy-C1-6alkyl optionally substituted with one or more substituents each independently selected from halo, cyano, hydroxy, NR9R10, -C (> = O) -NR9R10, -C (> = O) -C1-6 alkyl , -C (> = O) -O-C1-6-alkyl, -C (> = O) -polyhaloalkyl-C1-6, -C (> = O) -OpolyhaloalkylC1-6 or R7; C2-6 alkenyl optionally substituted with one or more substituents each independently selected from halo, cyano, hydroxy, NR9R10, -C (> = O) -NR9R10, -C (> = O) -C1-6 alkyl, -C ( > = O) -O-C1-6-alkyl, -C (> = O) -polyhaloalkyl-C1-6, -C (> = O) -O-polyhaloalkyl-C1-6 or R7; C2-6 alkynyl optionally substituted with one or more substituents each independently selected from halo, cyano, hydroxy, NR9R10, -C (> = O) -NR9R10, -C (> = O) -C1-6 alkyl, -C (> = O) -O-C1-6-alkyl, -C (> = O) -polyhaloalkyl-C1-6, -C (> = O) -O-polyhaloalkyl-C1-6 or R7; -C (> = N-O-R8) -C1-4alkyl; R7 or -X3-R7. |
| priorityDate | 2004-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 313.